11 – 20 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Conservative Management First Strategy in Aortic Vascular Graft and Endograft Infections
(
- Contribution to journal › Article
-
Mark
Metabolic tumour volume in Hodgkin lymphoma—A comparison between manual and AI-based analysis
2023) In Clinical Physiology and Functional Imaging(
- Contribution to journal › Article
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
(
- Contribution to journal › Article
-
Mark
Re : Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017
(
- Contribution to journal › Letter
-
Mark
[18F]PSMA-1007 renal uptake parameters: Reproducibility and relationship to estimated glomerular filtration rate
(
- Contribution to journal › Article
-
Mark
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging.
(
- Contribution to journal › Article
- 2022
-
Mark
Relationship between somatostatin receptor expressing tumour volume and health-related quality of life in patients with metastatic GEP-NET
(
- Contribution to journal › Article
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
(
- Contribution to journal › Article
-
Mark
Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
(
- Contribution to journal › Article
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
(
- Contribution to journal › Article